SlideShare ist ein Scribd-Unternehmen logo
1 von 19
Downloaden Sie, um offline zu lesen
by Rakesh
1
MEANINGFUL USE
Agenda
2
 What is meaningful use?
 CMS incentive program.
 Benefits.
 Legislation.
 Stages of meaningful use.
 Barriers.
 Penalties
EHR
3
 Electronic health information about patients that
is capable of being shared across different
health care settings.
 EHR can provide many benefits for providers and
their patients, but the benefits depend on how
they're used.
What is meaningful use?
4
 Set of standards by the CMS Incentive
Programs that
 governs the use of electronic health records and
 Allows eligible providers and hospitals to earn
incentive payments by meeting specific criteria.
The Medicare & Medicaid EHR
Incentive Program
5
 Provide incentive payments to eligible
professionals, eligible hospitals and critical
access hospitals (CAHs).
 Can receive up to
 $44,000 (Medicare, 2011 through 2016)
 $63,750 (Medicaid, 2011 through 2021)
 Maximum incentive payment - participation by
2012.
Goal
6
To promote the spread of electronic health records to
improve health care in the United States.
Benefits
7
 Complete and accurate information:
 provide the best possible care.
 Providers will know more about their patients.
 Better access to information:
 diagnose health problems earlier.
 Information can be shared among hospitals.
 Patient empowerment:
 Patients role.
 Records can be shared securely to their families.
Legislation
8
HITECH Act
HHS
Programs to improve
health care quality
Promotion of health IT like
EHR
Authority
To
establish
9
 Incentive Program for EHR: Issued by CMS,
define the minimum requirements that providers
must meet through their use of certified EHR
technology in order to qualify for the payment.
 Standards and Certification Criteria for
EHR: Issued by ONC, defines the technical
capabilities for certified EHR technology.
Stages of meaningful use
10
Stage-1 (2011-2012)
11
 Details the requirements for the use of
requirements for the use of EHR systems by
hospitals and eligible health care professionals.
 MU criteria for eligible professionals
 15 core objectives (mandatory)
 5 out of 10 from menu set objectives(choice)
 MU criteria for eligible hospitals
 14 core objectives (mandatory)
 5 out of 10 from menu set objectives (choice)
Core Requirements
(mandatory)
12
 Use computerized order entry for medication orders.
 Implement drug-drug, drug-allergy checks.
 Generate and transmit permissible prescriptions electronically.
 Record demographics.
 Maintain an up-to-date problem list of current and active diagnoses.
 Maintain active medication list.
 Maintain active medication allergy list.
 Record and chart changes in vital signs.
 Record smoking status for patients 13 years old or older.
 Implement one clinical decision support rule.
 Report ambulatory quality measures to CMS or the States.
 Provide patients with an electronic copy of their health information
upon request.
 Provide clinical summaries to patients for each office visit.
 Capability to exchange key clinical information electronically among
providers and patient authorized entities.
 Protect electronic health information (privacy & security)
Menu Requirements (optional)
13
 Implement drug-formulary checks.
 Incorporate clinical lab-test results into certified EHR as structured data.
 Generate lists of patients by specific conditions to use for quality
improvement, reduction of disparities, research, and outreach.
 Send reminders to patients per patient preference for preventive/ follow-
up care
 Provide patients with timely electronic access to their health information
(including lab results, problem list, medication lists, allergies)
 Use certified EHR to identify patient-specific education resources and
provide to patient if appropriate.
 Perform medication reconciliation as relevant
 Provide summary care record for transitions in care or referrals.
 Capability to submit electronic data to immunization registries and
actual submission.
 Capability to provide electronic syndromic surveillance data to public
health agencies and actual transmission.
Stage-2 (2014)
14
 Released in August 2012.
 Some stage-1 menu list items will move to the
stage 2 core list.
 MU criteria for eligible professionals
 17 core objectives (mandatory)
 3 out of 6 from menu set objectives(choice)
 MU criteria for eligible hospitals
 16 core objectives (mandatory)
 3 out of 6 from menu set objectives (choice)
Stage-3 (2016)
15
 Objectives has not yet defined.
 Likely to follow the same format as its
predecessors.
Milestone Timeline
16
Barriers to adoption
17
 Start-up costs
 Maintenance costs
 Training costs
Penalties
18
 Medicare:
 No payments after 2014.
 1% to 5% penalty of Medicare reimbursement after
2015.
 Medicaid:
 There are no penalties.
THANK YOU
19

Weitere ähnliche Inhalte

Andere mochten auch

Ethics is good business mandrin28 jan05 v
Ethics is good business mandrin28 jan05 vEthics is good business mandrin28 jan05 v
Ethics is good business mandrin28 jan05 vGraham Settle
 
Collaborative engineering solutions and challenges in the development of spac...
Collaborative engineering solutions and challenges in the development of spac...Collaborative engineering solutions and challenges in the development of spac...
Collaborative engineering solutions and challenges in the development of spac...Daniele Gianni
 
Uts media pembelajaran
Uts media pembelajaranUts media pembelajaran
Uts media pembelajaranIka R
 
A framework for distributed control and building performance simulation
A framework for distributed control and building performance simulationA framework for distributed control and building performance simulation
A framework for distributed control and building performance simulationDaniele Gianni
 
ModelicaML Value Bindings for Automated Model Composition
ModelicaML Value Bindings for Automated Model CompositionModelicaML Value Bindings for Automated Model Composition
ModelicaML Value Bindings for Automated Model CompositionDaniele Gianni
 
Calibration of Deployment Simulation Models - A Multi-Paradigm Modelling Appr...
Calibration of Deployment Simulation Models - A Multi-Paradigm Modelling Appr...Calibration of Deployment Simulation Models - A Multi-Paradigm Modelling Appr...
Calibration of Deployment Simulation Models - A Multi-Paradigm Modelling Appr...Daniele Gianni
 
The Beauty of Mathematics
The Beauty of MathematicsThe Beauty of Mathematics
The Beauty of MathematicsNishtha Pathak
 
jEQN a java-based language for the distributed simulation of queueing networks
jEQN a java-based language for the distributed simulation of queueing networksjEQN a java-based language for the distributed simulation of queueing networks
jEQN a java-based language for the distributed simulation of queueing networksDaniele Gianni
 
Modules for reusable and collaborative modeling of biological mathematical sy...
Modules for reusable and collaborative modeling of biological mathematical sy...Modules for reusable and collaborative modeling of biological mathematical sy...
Modules for reusable and collaborative modeling of biological mathematical sy...Daniele Gianni
 
Ika sherlyta 1005309
Ika sherlyta 1005309Ika sherlyta 1005309
Ika sherlyta 1005309Ika R
 
Simj a framework to develop distributed simulators scsc06
Simj a framework to develop distributed simulators   scsc06Simj a framework to develop distributed simulators   scsc06
Simj a framework to develop distributed simulators scsc06Daniele Gianni
 
Automated Performance Analysis of Business Processes
Automated Performance Analysis of Business ProcessesAutomated Performance Analysis of Business Processes
Automated Performance Analysis of Business ProcessesDaniele Gianni
 
SysML to Discrete-event Simulation to Analyze Electronic Assembly Systems
SysML to Discrete-event Simulation to Analyze Electronic Assembly SystemsSysML to Discrete-event Simulation to Analyze Electronic Assembly Systems
SysML to Discrete-event Simulation to Analyze Electronic Assembly SystemsDaniele Gianni
 
DDML a support for communication in m&s
DDML a support for communication in m&sDDML a support for communication in m&s
DDML a support for communication in m&sDaniele Gianni
 
BOM2UML: Integrating BOM Specifications into UML-based Development Environments
BOM2UML: Integrating BOM Specifications into UML-based Development EnvironmentsBOM2UML: Integrating BOM Specifications into UML-based Development Environments
BOM2UML: Integrating BOM Specifications into UML-based Development EnvironmentsDaniele Gianni
 
Anatomical Model Database
Anatomical Model DatabaseAnatomical Model Database
Anatomical Model DatabaseDaniele Gianni
 
Modelling Methodologies in Support of Complex Systems of Systems Design and I...
Modelling Methodologies in Support of Complex Systems of Systems Design and I...Modelling Methodologies in Support of Complex Systems of Systems Design and I...
Modelling Methodologies in Support of Complex Systems of Systems Design and I...Daniele Gianni
 
Simulation assisted elicitation and validation of behavioral specifications f...
Simulation assisted elicitation and validation of behavioral specifications f...Simulation assisted elicitation and validation of behavioral specifications f...
Simulation assisted elicitation and validation of behavioral specifications f...Daniele Gianni
 
Collaborative development and cataloguing of simulation and calculation model...
Collaborative development and cataloguing of simulation and calculation model...Collaborative development and cataloguing of simulation and calculation model...
Collaborative development and cataloguing of simulation and calculation model...Daniele Gianni
 
SimArch: un'architectura software per lo sviluppo di sistemi di simulatione d...
SimArch: un'architectura software per lo sviluppo di sistemi di simulatione d...SimArch: un'architectura software per lo sviluppo di sistemi di simulatione d...
SimArch: un'architectura software per lo sviluppo di sistemi di simulatione d...Daniele Gianni
 

Andere mochten auch (20)

Ethics is good business mandrin28 jan05 v
Ethics is good business mandrin28 jan05 vEthics is good business mandrin28 jan05 v
Ethics is good business mandrin28 jan05 v
 
Collaborative engineering solutions and challenges in the development of spac...
Collaborative engineering solutions and challenges in the development of spac...Collaborative engineering solutions and challenges in the development of spac...
Collaborative engineering solutions and challenges in the development of spac...
 
Uts media pembelajaran
Uts media pembelajaranUts media pembelajaran
Uts media pembelajaran
 
A framework for distributed control and building performance simulation
A framework for distributed control and building performance simulationA framework for distributed control and building performance simulation
A framework for distributed control and building performance simulation
 
ModelicaML Value Bindings for Automated Model Composition
ModelicaML Value Bindings for Automated Model CompositionModelicaML Value Bindings for Automated Model Composition
ModelicaML Value Bindings for Automated Model Composition
 
Calibration of Deployment Simulation Models - A Multi-Paradigm Modelling Appr...
Calibration of Deployment Simulation Models - A Multi-Paradigm Modelling Appr...Calibration of Deployment Simulation Models - A Multi-Paradigm Modelling Appr...
Calibration of Deployment Simulation Models - A Multi-Paradigm Modelling Appr...
 
The Beauty of Mathematics
The Beauty of MathematicsThe Beauty of Mathematics
The Beauty of Mathematics
 
jEQN a java-based language for the distributed simulation of queueing networks
jEQN a java-based language for the distributed simulation of queueing networksjEQN a java-based language for the distributed simulation of queueing networks
jEQN a java-based language for the distributed simulation of queueing networks
 
Modules for reusable and collaborative modeling of biological mathematical sy...
Modules for reusable and collaborative modeling of biological mathematical sy...Modules for reusable and collaborative modeling of biological mathematical sy...
Modules for reusable and collaborative modeling of biological mathematical sy...
 
Ika sherlyta 1005309
Ika sherlyta 1005309Ika sherlyta 1005309
Ika sherlyta 1005309
 
Simj a framework to develop distributed simulators scsc06
Simj a framework to develop distributed simulators   scsc06Simj a framework to develop distributed simulators   scsc06
Simj a framework to develop distributed simulators scsc06
 
Automated Performance Analysis of Business Processes
Automated Performance Analysis of Business ProcessesAutomated Performance Analysis of Business Processes
Automated Performance Analysis of Business Processes
 
SysML to Discrete-event Simulation to Analyze Electronic Assembly Systems
SysML to Discrete-event Simulation to Analyze Electronic Assembly SystemsSysML to Discrete-event Simulation to Analyze Electronic Assembly Systems
SysML to Discrete-event Simulation to Analyze Electronic Assembly Systems
 
DDML a support for communication in m&s
DDML a support for communication in m&sDDML a support for communication in m&s
DDML a support for communication in m&s
 
BOM2UML: Integrating BOM Specifications into UML-based Development Environments
BOM2UML: Integrating BOM Specifications into UML-based Development EnvironmentsBOM2UML: Integrating BOM Specifications into UML-based Development Environments
BOM2UML: Integrating BOM Specifications into UML-based Development Environments
 
Anatomical Model Database
Anatomical Model DatabaseAnatomical Model Database
Anatomical Model Database
 
Modelling Methodologies in Support of Complex Systems of Systems Design and I...
Modelling Methodologies in Support of Complex Systems of Systems Design and I...Modelling Methodologies in Support of Complex Systems of Systems Design and I...
Modelling Methodologies in Support of Complex Systems of Systems Design and I...
 
Simulation assisted elicitation and validation of behavioral specifications f...
Simulation assisted elicitation and validation of behavioral specifications f...Simulation assisted elicitation and validation of behavioral specifications f...
Simulation assisted elicitation and validation of behavioral specifications f...
 
Collaborative development and cataloguing of simulation and calculation model...
Collaborative development and cataloguing of simulation and calculation model...Collaborative development and cataloguing of simulation and calculation model...
Collaborative development and cataloguing of simulation and calculation model...
 
SimArch: un'architectura software per lo sviluppo di sistemi di simulatione d...
SimArch: un'architectura software per lo sviluppo di sistemi di simulatione d...SimArch: un'architectura software per lo sviluppo di sistemi di simulatione d...
SimArch: un'architectura software per lo sviluppo di sistemi di simulatione d...
 

Kürzlich hochgeladen

Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxtadehabte
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medicationMohamadAlhes
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxEx WHO/USAID
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Rheumatoid arthritis - Musculoskeletal disorders.ppt
Rheumatoid arthritis - Musculoskeletal disorders.pptRheumatoid arthritis - Musculoskeletal disorders.ppt
Rheumatoid arthritis - Musculoskeletal disorders.pptraviapr7
 
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSapna Thakur
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
Hypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptxHypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptxAkshay Shetty
 
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptx
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptxChronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptx
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptxSasikiranMarri
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..AneriPatwari
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfDivya Kanojiya
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfDivya Kanojiya
 

Kürzlich hochgeladen (20)

Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptx
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medication
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptx
 
JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Rheumatoid arthritis - Musculoskeletal disorders.ppt
Rheumatoid arthritis - Musculoskeletal disorders.pptRheumatoid arthritis - Musculoskeletal disorders.ppt
Rheumatoid arthritis - Musculoskeletal disorders.ppt
 
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
Hypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptxHypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptx
 
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptx
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptxChronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptx
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptx
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdf
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdf
 

Meaningful use: Medicare EHR Incentive Program

  • 2. Agenda 2  What is meaningful use?  CMS incentive program.  Benefits.  Legislation.  Stages of meaningful use.  Barriers.  Penalties
  • 3. EHR 3  Electronic health information about patients that is capable of being shared across different health care settings.  EHR can provide many benefits for providers and their patients, but the benefits depend on how they're used.
  • 4. What is meaningful use? 4  Set of standards by the CMS Incentive Programs that  governs the use of electronic health records and  Allows eligible providers and hospitals to earn incentive payments by meeting specific criteria.
  • 5. The Medicare & Medicaid EHR Incentive Program 5  Provide incentive payments to eligible professionals, eligible hospitals and critical access hospitals (CAHs).  Can receive up to  $44,000 (Medicare, 2011 through 2016)  $63,750 (Medicaid, 2011 through 2021)  Maximum incentive payment - participation by 2012.
  • 6. Goal 6 To promote the spread of electronic health records to improve health care in the United States.
  • 7. Benefits 7  Complete and accurate information:  provide the best possible care.  Providers will know more about their patients.  Better access to information:  diagnose health problems earlier.  Information can be shared among hospitals.  Patient empowerment:  Patients role.  Records can be shared securely to their families.
  • 8. Legislation 8 HITECH Act HHS Programs to improve health care quality Promotion of health IT like EHR Authority To establish
  • 9. 9  Incentive Program for EHR: Issued by CMS, define the minimum requirements that providers must meet through their use of certified EHR technology in order to qualify for the payment.  Standards and Certification Criteria for EHR: Issued by ONC, defines the technical capabilities for certified EHR technology.
  • 11. Stage-1 (2011-2012) 11  Details the requirements for the use of requirements for the use of EHR systems by hospitals and eligible health care professionals.  MU criteria for eligible professionals  15 core objectives (mandatory)  5 out of 10 from menu set objectives(choice)  MU criteria for eligible hospitals  14 core objectives (mandatory)  5 out of 10 from menu set objectives (choice)
  • 12. Core Requirements (mandatory) 12  Use computerized order entry for medication orders.  Implement drug-drug, drug-allergy checks.  Generate and transmit permissible prescriptions electronically.  Record demographics.  Maintain an up-to-date problem list of current and active diagnoses.  Maintain active medication list.  Maintain active medication allergy list.  Record and chart changes in vital signs.  Record smoking status for patients 13 years old or older.  Implement one clinical decision support rule.  Report ambulatory quality measures to CMS or the States.  Provide patients with an electronic copy of their health information upon request.  Provide clinical summaries to patients for each office visit.  Capability to exchange key clinical information electronically among providers and patient authorized entities.  Protect electronic health information (privacy & security)
  • 13. Menu Requirements (optional) 13  Implement drug-formulary checks.  Incorporate clinical lab-test results into certified EHR as structured data.  Generate lists of patients by specific conditions to use for quality improvement, reduction of disparities, research, and outreach.  Send reminders to patients per patient preference for preventive/ follow- up care  Provide patients with timely electronic access to their health information (including lab results, problem list, medication lists, allergies)  Use certified EHR to identify patient-specific education resources and provide to patient if appropriate.  Perform medication reconciliation as relevant  Provide summary care record for transitions in care or referrals.  Capability to submit electronic data to immunization registries and actual submission.  Capability to provide electronic syndromic surveillance data to public health agencies and actual transmission.
  • 14. Stage-2 (2014) 14  Released in August 2012.  Some stage-1 menu list items will move to the stage 2 core list.  MU criteria for eligible professionals  17 core objectives (mandatory)  3 out of 6 from menu set objectives(choice)  MU criteria for eligible hospitals  16 core objectives (mandatory)  3 out of 6 from menu set objectives (choice)
  • 15. Stage-3 (2016) 15  Objectives has not yet defined.  Likely to follow the same format as its predecessors.
  • 17. Barriers to adoption 17  Start-up costs  Maintenance costs  Training costs
  • 18. Penalties 18  Medicare:  No payments after 2014.  1% to 5% penalty of Medicare reimbursement after 2015.  Medicaid:  There are no penalties.